|
WO2020190742A1
|
|
Peptidomimetic macrocycles and uses thereof
|
|
WO2020112868A1
|
|
Combination therapy of peptidomimetic macrocycles
|
|
WO2020023502A1
|
|
Peptidomimetic macrocycles and uses thereof
|
|
US2018371021A1
|
|
Peptidomimetic macrocycles and uses thereof
|
|
US2018273587A1
|
|
Warhead-containing peptidomimetic macrocycles as modulators of bfl-1
|
|
WO2017218949A2
|
|
Peptidomimetic macrocycles and uses thereof
|
|
WO2017205786A1
|
|
Cell permeable peptidomimetic macrocycles
|
|
WO2017165299A2
|
|
Companion diagnostic tool for peptidomimetic macrocycles
|
|
US2017107252A1
|
|
Peptidomimetic macrocycles as modulators of MCL-1
|
|
MX2018002723A
|
|
Peptidomimetic macrocycles and uses thereof.
|
|
US2017037105A1
|
|
Peptidomimetic macrocycles
|
|
US2017002042A1
|
|
Peptidomimetic macrocycles
|
|
AU2016235424A1
|
|
Peptidomimetic macrocycles and uses thereof
|
|
AU2015320545A1
|
|
Peptidomimetic macrocycles and formulations thereof
|
|
KR20170058424A
|
|
Peptidomimetic macrocycles and uses thereof
|
|
US2017037086A1
|
|
Peptidomimetic macrocycles with pth activity
|
|
AU2014201956A1
|
|
Bis-sulfhydryl macrocyclization systems
|
|
AU2014201269A1
|
|
Therapeutic peptidomimetic macrocycles
|
|
WO2014138429A2
|
|
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
|
MX2015005244A
|
|
Disubstituted amino acids and methods of preparation and use thereof.
|
